Teng,Renli

Institution: AstraZeneca LP, Wilmington, DE 19850-5437, USA

Research Interests: Patients, Platelet, Platelet Aggregation, Acute Coronary Syndromes, Syndromes, Inhibition, Concentration, Plasma, Adenosine, Risk, Time, Cytochrome, Cytochrome P450, Administration, Acute Coronary Syndrome, Syndrome, Treatment, Absorption, Adjustment, Pharmacokinetics